Environment, Health and Safety Online The site for free, objective information you can use! Search the site | |||||||||||
| Contact Info for: Regs: Data: Search EPA databases Other Topics: | Anthrax FAQs
| ||||||||||
| |||||||||||
Who should get vaccinated against anthrax? The Advisory Committee on Immunization Practices has recommend anthrax vaccination for the following groups:
What is the protocol for anthrax vaccination? The immunization consists of three subcutaneous injections given 2 weeks apart followed by three additional subcutaneous injections given at 6, 12, and 18 months. Annual booster injections of the vaccine are recommended thereafter. Are there adverse reactions to the anthrax vaccine? Mild local reactions occur in 30% of recipients and consist of slight tenderness and redness at the injection site. Severe local reactions are infrequent and consist of extensive swelling of the forearm in addition to the local reaction. Systemic reactions occur in fewer than 0.2% of recipients. How is anthrax diagnosed? Where can I get more information about the recent Department of Defense decision to require men and women in Q: Is there an approved treatment for anthrax? A: Yes. Three types of antiobiotics are approved for anthrax: ciprofloxacin, tetracyclines (including doxycycline), and penicillins. For people who have been exposed to anthrax but do not have symptoms, 60 days of one of these antibiotics is given to reduce the risk or progression of disease due to inhaled anthrax. Q: Does the government have a plan in place to make Cipro available if there were mass exposure to anthrax? A: Yes. Under emergency plans, the Federal government would ship appropriate antibiotics from its stockpile to wherever they are needed. Q: Should individual consumers ask their physicians to write a prescription for Cipro, so they have it on hand in case it's needed? A: No. Any needed antibiotics from the current stockpile will be made available if they are needed. In the meantime, Cipro should not be prescribed unless there is a clearly indicated need, so that the drug will be available as the need arises for the standard infections for which it is used. Q: What is FDA telling physicians and other health professionals about prescriptions for Cipro? A: Although FDA does not regulate the practice of medicine, the agency is strongly recommending that physicians not prescribe Cipro for individual patients to have on hand for possible use against inhaled anthrax. In addition to the potential influence on supply of the drug, indiscriminate prescribing and widespread use of Cipro could hasten the development of drug-resistant organisms |